Psychophysiological Effects of Thorax Wraps With Ginger and Mustard Flour (SWI_02)

Psychophysiological Efficacy of Thorax Wraps With Ginger or Mustard Flour in Comparison to Wraps With Warm Water in Healthy Subjects - a Randomized, Placebo-controlled, Three-armed Study With Cross-over Design

In integrative medicine wraps are applied for different indications. In this study the effects of thorax with ginger and mustard flour are investigated under standardized conditions. Heart rate variability, well being, warmth distribution and respiratory activity of healthy subjects will be measured.

Study Overview

Detailed Description

The purpose of this study is to investigate the effects of different thorax wraps in healthy subjects. Subjects undergo three different interventions (wraps with ginger flour, mustard flour or warm water (placebo)) on three different days. Heart rate variability and respiratory activity is measured for ten minutes before, during (up to 20 minutes) and for ten minutes after each thorax wrap. To investigate the effects on heat development and regulation, photos are taken with a thermographic infrared camera at various moments in time. Participants are asked to fill in questionnaires referring to their subjective perceptions of warmth, bodily warmth distribution and wellbeing. The order of the thorax wrap interventions is randomized.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baden-Württemberg
      • Filderstadt, Baden-Württemberg, Germany, 70794
        • Filderklinik

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Signed informed consent.

Exclusion Criteria:

Inflectional disease with body temperature > 38 °C. Skin damage on the thorax area Known intolerance or hypersensitivity to mustard or ginger products. Heart failure. Asthma bronchiale. Taking medication with influence on heart rate variability ( mainly tricyclic antidepressants and beta blocker).

Consumption of coffee or nicotine less than three hours before the intervention.

Pregnancy. Deficient knowledge of the German language.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Thorax wrap with ginger flour (Zingiberis Rhizoma plv.)
Thorax wrap with ginger flour, duration max. 20 minutes
Active Comparator: Thorax wrap with mustard flour (Sinapis nigrea semen)
Thorax wrap with mustard flour, duration max 20 minutes
Placebo Comparator: Thorax wrap with warm water (placebo)
Thorax wrap with warm water (placebo), duration: 20 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in temperature
Time Frame: max. 40 minutes
Temperature (in °Celsius) of feet, lower legs, hands and face measured with a thermographic infrared camera (pre-post-comparison)
max. 40 minutes
Respiratory activity (expiratory CO2 and NO-measurement)
Time Frame: max. 40 minutes
Physiological parameters are measured for pre-post comparison.
max. 40 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Basler Mood Questionnaire (BBS)
Time Frame: 40 minutes
filled in by the participants nine times (before and after the thorax wrap and 10 minutes after the intervention)
40 minutes
Herdecker Wärmeempfindungs-Fragebogen (HeWef)
Time Frame: 40 minutes
filled in by the participants nine times (before and after the thorax wrap and 10 minutes after the intervention)
40 minutes
Warmth perception and skin irritation (NRS)
Time Frame: 40 minutes
Warmth perception and skin irritation during the intervention every minute (measured with a numeric rating scale).
40 minutes
heart rate variability -Parameter (HRV)
Time Frame: Physiological parameters are measured over a period of 40 minutes
Standard Deviation of Normal to Normal (heart rate) (SDNN)
Physiological parameters are measured over a period of 40 minutes
heart rate variability -Parameter (HRV)
Time Frame: Physiological parameters are measured over a period of 40 minutes
Root Mean Square of the Successive Differences (RMSSD)
Physiological parameters are measured over a period of 40 minutes
heart rate variability -Parameter (HRV)
Time Frame: Physiological parameters are measured over a period of 40 minutes
ratio low frequency to high frequency (LF/HF)
Physiological parameters are measured over a period of 40 minutes
heart rate variability -Parameter (HRV)
Time Frame: Physiological parameters are measured over a period of 40 minutes
very low frequency (VLF)
Physiological parameters are measured over a period of 40 minutes
heart rate variability -Parameter (HRV)
Time Frame: Physiological parameters are measured over a period of 40 minutes
NN50 (the number of pairs of successive NNs that differ by more than 50 ms)
Physiological parameters are measured over a period of 40 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jan Vagedes, Dr., ARCIM-Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

November 5, 2014

First Submitted That Met QC Criteria

November 6, 2014

First Posted (Estimate)

November 7, 2014

Study Record Updates

Last Update Posted (Actual)

May 9, 2018

Last Update Submitted That Met QC Criteria

May 8, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Placebo

3
Subscribe